TNF receptor 1 (TNFR1) is expressed in most cell ... selective targeting of TNFR1-mediated signaling while sparing TNFR2 activation may lessen adverse effects of anti-TNF therapies in the CNS.

Fas signaling may also be involved in T ... to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747–1756 (1989).

Discovery of innate immune receptor "brake" Siglec-E offers a novel therapeutic target to prevent organ transplant rejection ...

Nektar Therapeutics’s NKTR share price has dipped by 5.72%, which has investors questioning if this is right time to buy.

and soluble TNF receptor 1 (sTNFR1). We are currently enrolling patients in a larger Phase 2b clinical trial that will investigate isomyosamine’s effect on cellular inflammation and recovery of ...

J Neuroinflammation © 2008 McCoy and Tansey; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons ...